T. Sacha, “Superior efficacy of nilotinib vs imatinib in patients with chronic myeloid leukemia in chronic phase. ENESTnd and ENESTcmr current results analysis”, OncoReview, vol. 3, no. 1(9), pp. 37-45, Mar. 2013.